The acquisition expands Medtronic’s portfolio of advanced cardiac ablation products, according to a Jan. 10 news release. Affera’s technologies include the Affera Prism-1 cardiac mapping and navigation platform and the Sphere-9 cardiac ablation catheter.
Terms of the acquisition were not disclosed. The deal is expected to close in the first half of Medtronic’s fiscal year 2023.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
